Synthetic high-density lipoprotein nanodiscs for personalized immunotherapy against gliomas.

CONCLUSIONS: Overall, our strategy provides a general roadmap for combination immunotherapy against gliomas and other cancer types.
PMID: 32439701 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - May 20, 2020 Category: Cancer & Oncology Authors: Scheetz L, Kadiyala P, Sun X, Son S, Najafabadi AH, Aikins M, Lowenstein PR, Schwendeman A, Castro MG, Moon JJ Tags: Clin Cancer Res Source Type: research